Akèy › Kansè Poumon ki pa ti selil › New Jersey › Edison
Etid klinik pou Kansè Poumon ki pa ti selil nan Edison, NJ
47 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Astera Cancer Care /ID# 272359, East Brunswick · 6 mi lwen
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 2/3
- Astera Cancer Care /ID# 277570, East Brunswick · 6 mi lwen
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Ap rekriteFaz 1/2
- Astera Cancer Care /ID# 271915, East Brunswick · 6 mi lwen
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- START New Jersey, East Brunswick · 6 mi lwen
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #88, East Brunswick · 6 mi lwen
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- START New Jersey, East Brunswick · 6 mi lwen
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, New Brunswick · 3 mi lwen
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Ap rekriteFaz 2/3
- Astera Cancer Care, East Brunswick · 6 mi lwen
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Ap rekriteFaz 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Ap rekriteFaz 3
- Clinical Study Site, New Brunswick · 3 mi lwen
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Ap rekriteFaz 3
- Astera Cancer Care, Edison
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Ap rekriteFaz 2/3
- Local Institution - 007-975-A, Somerset · 4 mi lwen
- Local Institution - 007-975-B, Somerset · 4 mi lwen
- Local Institution - 007-975-C, Somerset · 4 mi lwen
- ak 2 plis
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Using Urine Samples to Identify Lung Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- Astera Cancer Care, East Brunswick · 6 mi lwen
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Ap rekriteFaz 1/2
- START New Jersey East Brunswick, East Brunswick · 6 mi lwen
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Ap rekriteFaz 1
- Site 104 - START New Jersey, East Brunswick · 6 mi lwen
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- Rutgers Cancer Institute, New Brunswick · 3 mi lwen
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Ap rekriteFaz 2
- Astera Cancer Care, East Brunswick · 6 mi lwen
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15 mi lwen
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- START Astera, LLC, East Brunswick · 6 mi lwen
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Ap rekriteFaz 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Virtua Voorhees, Voorhees Township · 5 mi lwen
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Virtua Voorhees, Voorhees Township · 5 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Virtua Voorhees, Voorhees Township · 5 mi lwen
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Virtua Voorhees, Voorhees Township · 5 mi lwen
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Ap rekriteFaz 1/2
- START, Astera, East Brunswick · 6 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, New Brunswick · 3 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Edison
- Kansè nan tete68 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat29 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Myelom Miltip22 etid
- Kansè vejik21 etid
- Leksemi mieloïd egi20 etid
- Kansè ovè20 etid
- Kansè Metastatik20 etid
- Kansè Endomèt19 etid
- Kasinom Selil Transizyonèl (Urotelyal)18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.